書誌事項
- タイトル別名
-
- Potential Drug-Drug Interactions among Three or More Drugs: A Retrospective Multi-center Study in Pharmacies in the Kojima Region, Okayama
- 3シュルイ イジョウ ノ ヤクザイ フクヨウジ ノ ヤクブツ カン ソウゴ サヨウ ニ カンスル コウホウ シテキ ケントウ : オカヤマケン コジマ チク ノ ホケン ヤッキョク ニ オケル タシセツ キョウドウ ケンキュウ
この論文をさがす
抄録
<p>Drug-drug interactions (DDIs) are responsible for an increase in the incidence of adverse drug reactions. Although CYP is known to be involved in metabolic processes, the DDIs among three or more drugs that involve the same CYP molecular species have not been fully investigated. In this study, we retrospectively examined the relationship between the number of drugs and potential DDIs in metabolic processes involving CYPs in patients who picked up their prescribed drugs at 11 pharmacies in the Kojima Branch of the Okayama Pharmaceutical Association. We found that 66.5% of the 924 patients had potential DDIs; more than half of the patients who took six or more drugs had potential DDIs among three or more drugs. The mean number of CYP3A4-related drugs involved in potential DDIs was 3.52±1.56 in patients who took seven drugs, suggesting the need for careful monitoring of specific symptoms and blood test results for the early detection of adverse drug reactions caused by DDIs among three or more drugs.</p>
収録刊行物
-
- 薬学雑誌
-
薬学雑誌 141 (7), 979-984, 2021-07-01
公益社団法人 日本薬学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390007072283730432
-
- NII論文ID
- 130008059961
-
- NII書誌ID
- AN00284903
-
- ISSN
- 13475231
- 00316903
-
- NDL書誌ID
- 031598292
-
- PubMed
- 34193658
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可